Last reviewed · How we verify

NCT04518111

Oxford UKA and HTO Post-market Clinical Study

ENROLLING BY INVITATION Last updated 23 May 2024
What this trial tests

trial in Knee Osteoarthritis in 370 participants. Enrolling by invitation.

Timeline
24 April 2021
Primary endpoint
30 September 2024
31 December 2024

Quick facts

Lead sponsorZimmer Biomet
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment370
Start date24 April 2021
Primary completion30 September 2024
Estimated completion31 December 2024
Sites1 location across China

Conditions studied

Sponsor

Zimmer Biomet — full company profile →

Who can join

Adults 18 to 85, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the performance and safety of medial UKA and HTO in the treatment of AMOA in term of functional outcome, radiographic assessment, range of motion, postoperative complications, revision rate and relevant health economics outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Zimmer Biomet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04518111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing